Rezulin Suits Dismissed by Judge
Citing insufficient evidence, a US District Court judge has dismissed nearly 30 lawsuits alleging that the diabetes drug Rezulin caused liver damage.
Citing insufficient evidence, a US District Court judge has dismissed nearly 30 lawsuits alleging that the diabetes drug Rezulin caused liver damage.
In response to a request by the FDA, drugmaker GlaxoSmithKline will add new warnings to the label of the ADHD drug Dexedrine, cautioning of the increased risk of heart problems among users.
A new study published in the August Archives of Dermatology shows that Accutane may cause more patients to develop high cholesterol, elevated liver enzyme levels, and high triglyceride numbers than stated on the drug’s packaging.
©2008 Einstein Law All Rights Reserved